Clinical Trials Browser

Recurrence × isatuximab × 90 days × Clear all

NCT05911321 2026-05-20

Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

Phase 2 Active not recruiting

6 enrolled 5 charts

Multiple Myeloma, Recurrence